Many preclinical and clinical studies have demonstrated upregulated VEGF in patients with HCC after receiving LITs [86,87,101,105,132,133,134,135,136,137,138,139,140,156,164,166,167,168,169,170]. Here, VEGFA is linked to hepatocellular carcinoma.